Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
12.18
+0.51 (4.37%)
May 12, 2026, 4:00 PM EDT - Market closed
Orthofix Medical Revenue
Orthofix Medical had revenue of $196.71M in the quarter ending March 31, 2026, with 1.58% growth. This brings the company's revenue in the last twelve months to $825.37M, up 2.59% year-over-year. In the year 2025, Orthofix Medical had annual revenue of $822.31M with 2.85% growth.
Revenue (ttm)
$825.37M
Revenue Growth
+2.59%
P/S Ratio
0.60
Revenue / Employee
$514,252
Employees
1,605
Market Cap
492.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 822.31M | 22.82M | 2.85% |
| Dec 31, 2024 | 799.49M | 52.85M | 7.08% |
| Dec 31, 2023 | 746.64M | 285.93M | 62.06% |
| Dec 31, 2022 | 460.71M | -3.77M | -0.81% |
| Dec 31, 2021 | 464.48M | 57.92M | 14.25% |
| Dec 31, 2020 | 406.56M | -53.39M | -11.61% |
| Dec 31, 2019 | 459.96M | 6.91M | 1.53% |
| Dec 31, 2018 | 453.04M | 19.22M | 4.43% |
| Dec 31, 2017 | 433.82M | 24.04M | 5.87% |
| Dec 31, 2016 | 409.79M | 13.30M | 3.35% |
| Dec 31, 2015 | 396.49M | -5.79M | -1.44% |
| Dec 31, 2014 | 402.28M | 4.67M | 1.17% |
| Dec 31, 2013 | 397.61M | -42.58M | -9.67% |
| Dec 31, 2012 | 440.19M | 4.67M | 1.07% |
| Dec 31, 2011 | 435.52M | -27.05M | -5.85% |
| Dec 31, 2010 | 462.57M | -83.06M | -15.22% |
| Dec 31, 2009 | 545.64M | 25.96M | 5.00% |
| Dec 31, 2008 | 519.68M | 29.35M | 5.99% |
| Dec 31, 2007 | 490.32M | 124.96M | 34.20% |
| Dec 31, 2006 | 365.36M | 52.06M | 16.61% |
| Dec 31, 2005 | 313.30M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 857.50M |
| Tactile Systems Technology | 343.52M |
| OrthoPediatrics | 243.30M |
| Cerus | 216.56M |
| Cytek Biosciences | 204.17M |
| Pacific Biosciences of California | 160.03M |
| Beta Bionics | 110.24M |
| NeuroPace | 99.53M |
OFIX News
- 6 days ago - Orthofix announces FITBONE innovation at POSNA 2026 meeting - TheFly
- 7 days ago - Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting - Business Wire
- 7 days ago - Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights - PRNewsWire
- 8 days ago - Orthofix Medical Earnings Call Transcript: Q1 2026 - Transcripts
- 8 days ago - Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance - Business Wire
- 18 days ago - Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX - Business Wire
- 22 days ago - Orthofix to Report First Quarter 2026 Financial Results - Business Wire
- 4 weeks ago - Orthofix announces spine leadership realignment - TheFly